bullish
high
✓ Verified against BSE filing
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Q3 FY26
FY26 organic revenue growth of 11-12%
Management reiterated confidence in delivering 11-12% organic revenue growth for the full fiscal year.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1
Q3 FY26
FY26 EBITDA margin of 27-28%
Management guided for EBITDA margin between 27-28% for FY26, despite GST pass-through and labor code impact.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1
Q3 FY26
Capex of ₹150-160 crore for FY26
Capex for FY26 expected at ₹150-160 crore, including investments in radiology centers and precision diagnostic center.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1